Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-12-13
1993-02-16
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514866, 424 9, A61K 3700, A61K 4900
Patent
active
051871548
ABSTRACT:
The invention relates to a method of diagnosing and treating individuals with diabetes or at risk to develop diabetes mellitus. In particular, gastric emptying determinations are used to assess risk. Risk or early symptoms associated with subsequent development of diabetes mellitus may be controlled or alleviated by delaying gastric emptying. Delay or
REFERENCES:
Dorland's Illustrated Medical Dictionary,26th ed. (W. B. Saunders Co. 1990) at 368-369.
Conn's 1989 Current Therapy, Robert E. Rakel (Ed.) (W. B. Saunders Co.) at 482-498.
Eisenbarth, New Eng. J. Med. (May 1986) 1360-1368.
Brown et al. Can. J. Phys. Pharmacol. (1983) 283-289 Abstract.
Horowitz et al. Diabetologia (1989) vol. 32 151-159.
Liddie et al J. Clin Inves vol. 77 (1986) 992-996.
Jenkins et al Diabetes vol. 39 (Jul. 1990).
Granneman CA 102(7) 60260u (1984).
Barnett CA 108(17) 148220r (1988).
Thompson et al., "Gastric Emptying as a Determinant of the Oral Glucose Tolerance Test", Gastroenterology, 82:51-55 (1982).
Brener et al., "Regulation of the Gastric Emptying of Glucose", Gastroenterology, 85:76-82 (1983).
Keshavarzian, et al., "Gastric Emptying in Patients with Insulin-Requiring Diabetes Mellitus", Am. J. Gastroenterology, 82(1):29-35 (1987).
Campbell, et al., "Gastric emptying in diabetic autonoic neuropathy", Gut, 18:462-467 (1977).
Horowitz, et al., "Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus", Diabetologia, 32:151-159 (1989).
Smout, J. J. P. M., Z. Gastroenterologie 24(Suppl. 2):45-54 (1986).
Pellegrini, et al., "Diagnosis and Treatment of Gastric Emptying Disorders", Am. J. Surg., 145:143-151 (1983).
Akkermans, et al., "Neural and Hormonal Control of Pyloric Sphincter Function", Gastroenterol. Suppl., 24:27-31 (1989).
Schwartz, et al., "Revision of the Oral Glucose Tolerance Test: A Pilot Study", Clinical Chemistry, 36(1):125-128 (1990).
Liddle, R. A., Federal Research in Progress, National Institute of Diabetes and Digestive and Kidney Diseases (1990).
Chaudhuri, T. K. and Fink, S., "Update: Pharmaceuticals and Gastric Emptying", Am. J. Gastroenterology, 85(3):223-231 (1990).
Liddle, et al., "Regulation of Gastric Emptying in Humans by Cholecstokinin", J. Clin. Invest., 77:992-996 (1986).
Liddle, et al., "Physiological Role for Cholecystokinin in Reducing Post-prandial Hyperglycemia in Humans", J. Clin. Invest., 81:1675-1681 (1988).
Jenkins, et al., Diabetes, 39:775-780 (1990).
Cohen, et al., "High Prevalence of Diabetes in Young Adulg Ethiopian Immigrants to Israel", Diabetes, 37:824-827 (1988).
Rowland, M. and Tozer, T. N., in Clinical Pharmacokinetics: Concepts and Applications, Second Edition, 117-129 (1989).
Jenkins, et al., "Metabolic Advantages of Increased Meal Frequency", The New England Journal of Medicine, 321(14):929-934 (1989).
Cowen, R., "Seeds of Protection: Ancestral menus may hold a message for diabetes-prone descendants", Science News, 137:350-351 (1990).
Vinik, A. I. and Jenkins, J. A., "Dietary Fiber in Management of Diabetes", Diabetes Care, 11(2):160-173 (1988).
Fiorucci, et al., Medline Abstract, Dig. Dis. Sci., 35(9):1089-97 (1990).
Dialog Search Abstracts, Items 1-8, Oct. 15, 1990.
Dialog Search Abstracts, Items 1-8, Oct. 10, 1990.
Phillips William
Schwartz Joyce G.
Board of Regents , The University of Texas System
Cashion Jr. Merrell C.
Celsa B.
LandOfFree
Diagnosis and treatment of humans with diabetes or at risk to de does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis and treatment of humans with diabetes or at risk to de, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis and treatment of humans with diabetes or at risk to de will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2148133